Your browser doesn't support javascript.
loading
Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab.
Vastesaeger, Nathan; Kutzbach, Abraham Garcia; Amital, Howard; Pavelka, Karel; Lazaro, María Alicia; Moots, Robert J; Wollenhaupt, Jürgen; Zerbini, Cristiano A F; Louw, Ingrid; Combe, Bernard; Beaulieu, Andre; Schulze-Koops, Hendrik; Dasgupta, Bhaskar; Fu, Bo; Huyck, Susan; Weng, Haoling H; Govoni, Marinella; Durez, Patrick.
Afiliação
  • Vastesaeger N; Department of Medical Affairs, MSD Danmark ApS, Ballerup, Denmark nathan.vastesaeger@merck.com.
  • Kutzbach AG; Department of Rheumatology, AGAR Francisco Marroquin University, Guatemala City, Guatemala.
  • Amital H; Department of Internal Medicine B and Research Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.
  • Pavelka K; Institute of Rheumatology and Clinic of Rheumatology, Charles University, Prague, Czech Republic.
  • Lazaro MA; Instituto de Asistencia Reumatologica Integral, Buenos Aires, Argentina.
  • Moots RJ; Department of Rheumatology, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK.
  • Wollenhaupt J; Department of Rheumatology, Klinik für Rheumatologie, Schön Klinik Hamburg-Eilbek, Hamburg, Germany.
  • Zerbini CA; Department of Rheumatology, Centro Paulista de Investigação Clinica, São Paulo, Brazil.
  • Louw I; Panorama Medical Centre, Cape Town, South Africa.
  • Combe B; Departement de Rhumatologie, Hôpital Lapeyronie, Montpellier University Hospital, Montpellier, France.
  • Beaulieu A; Centre de Rhumatologie St-Louis, Québec, Canada.
  • Schulze-Koops H; Division of Rheumatology and Clinical Immunology, Department of Medicine IV, University of Munich, Munich, Germany.
  • Dasgupta B; Department of Rheumatology, Southend University Hospital, Westcliff-on-Sea, Essex, UK.
  • Fu B; Department of Biostatistics.
  • Huyck S; Department of Biostatistics.
  • Weng HH; Clinical Development, Merck & Co, Inc., Kenilworth, NJ, USA.
  • Govoni M; Department of Immunology, MSD Italy, Global Medical Affairs, Rome, Italy.
  • Durez P; Department of Rheumatology, Université Catholique de Louvain, Brussels, Belgium.
Rheumatology (Oxford) ; 55(8): 1466-76, 2016 08.
Article em En | MEDLINE | ID: mdl-27114562
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article